Most cancers care is transferring in the direction of earlier detection, personalised therapy, and cheaper therapies, as advances in genomics and precision medication start to affect medical observe, oncologists mentioned.
The main target is shifting to figuring out most cancers threat earlier and tailoring therapy to particular person sufferers as a substitute of counting on commonplace protocols, oncologists mentioned forward of the Fortis Most cancers Summit 2026.
India reviews over 14 lakh new most cancers instances yearly, in keeping with the Indian Council of Medical Analysis (ICMR), underlining the necessity for earlier detection and improved entry to care.
“The way forward for most cancers care lies in collaboration, innovation, and the power to adapt proof into customized affected person care pathways,” mentioned Dr Nitesh Rohatgi, Principal Director, Medical Oncology, Fortis Memorial Analysis Institute, Gurugram.
Docs additionally highlighted the necessity to enhance entry to therapy by specializing in cost-effective therapies, significantly in markets equivalent to India, the place affordability stays a key concern.
Out-of-pocket expenditure continues to account for a big share of healthcare spending in India, making affordability a key problem in most cancers therapy, in keeping with authorities estimates.
There may be additionally better emphasis on screening and preventive care, particularly for cancers equivalent to cervical most cancers, the place early analysis can enhance outcomes.
“Oncology is at a transformative juncture the place scientific innovation, precision medication, and multidisciplinary care are redefining therapy outcomes,” mentioned Dr Ankur Bahl, Principal Director, Medical Oncology, Fortis Memorial Analysis Institute, Gurugram.
The Fortis Most cancers Summit 2026, a world convention, is scheduled to be held on Could 2–3 and can deliver collectively oncologists from India and abroad.
